Cargando…
Combined therapy of tocilizumab and corticosteroids in severe SARS-CoV-2 disease()
Autores principales: | González-Castro, A., Cuenca Fito, E., Fernandez, A., Escudero Acha, P., Rodríguez Borregán, J.C., Peñasco, Y. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier España, S.L.U.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8866085/ https://www.ncbi.nlm.nih.gov/pubmed/35256321 http://dx.doi.org/10.1016/j.medine.2022.02.013 |
Ejemplares similares
-
High flow oxygen therapy in the treatment of SARS-CoV-2 pneumonia()
por: González-Castro, A., et al.
Publicado: (2022) -
Mechanical power greater than 17 joules/min in patients with respiratory failure secondary to SARS-CoV-2 infection
por: González-Castro, A., et al.
Publicado: (2023) -
Terapia combinada de tocilizumab y corticoides en la enfermedad grave por SARS-CoV-2
por: González-Castro, A., et al.
Publicado: (2022) -
First and second wave of coronavirus-19 disease: A comparative study in patients hospitalized in an ICU of a third-level university hospital()
por: González-Castro, A., et al.
Publicado: (2022) -
Combination of airway pressure release ventilation with inverted inspiration-exhalation ratio and low-flow CO(2) removal devices with renal replacement therapy in refractory hypoxemia()
por: González-Castro, A., et al.
Publicado: (2021)